Sales rise 4.70% to Rs 41.89 crore
Net profit of Sharon Bio-Medicine declined 48.37% to Rs 2.37 crore in the quarter ended September 2020 as against Rs 4.59 crore during the previous quarter ended September 2019. Sales rose 4.70% to Rs 41.89 crore in the quarter ended September 2020 as against Rs 40.01 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales41.8940.01 5 OPM %11.1016.10 -PBDT5.256.93 -24 PBT2.374.59 -48 NP2.374.59 -48Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
